Dan-Dan Yang

Risk Management in First-in-Human Trials of Intravenous Drugs: Current Practices and Future Perspectives

A conceptual, stratified risk management framework is proposed that categorizes trials into low-, moderate-, and high-risk levels based on drug-related, procedural, and participant-specific variables and optimizes safety assurance in high-risk trials while avoiding the overutilization of resources in low-risk settings.